Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Opioid Use in Medicare Part D in 2022: Annual Review

The opioid crisis remains a public health emergency. In 2021, an estimated 82,310 opioid-related overdose deaths occurred in the United States. Identifying patients who are at risk for overdose or abuse is key to addressing this crisis. This data brief, Opioid Use in Medicare Part D in 2022: Annual Review, builds on our series of annual reports and provides information on opioid utilization among people enrolled in Medicare Part D in 2022. It provides 2022 data on the number of enrollees who received extreme amounts of opioids through Part D and those who appeared to be doctor shopping. It also identifies prescribers who ordered opioids for large numbers of these enrollees. In addition, the brief provides data on the number of enrollees who received drugs to treat opioid use disorder, the number of enrollees who experienced an opioid overdose, and the number of enrollees who received opioid overdose-reversal drugs.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Completed Centers for Medicare and Medicaid Services Opioid Use in Medicare Part D in 2022: Annual Review Office of Evaluation and Inspections OEI-02-23-00250 2024